Personalized Breast Cancer Treatment

51 – 60 of 148

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1001122?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
5
6
7
8
…
15
next »

2021
Mark Disseminated tumour cells from the bone marrow of early breast cancer patients : Results from an international pooled analysis
Hartkopf, Andreas D. ; Brucker, Sara Y. ; Taran, Florin Andrei ; Harbeck, Nadia ; von Au, Alexandra ; Naume, Bjørn ; Pierga, Jean Yves ; Hoffmann, Oliver ; Beckmann, Matthias W. and Rydén, Lisa ^LU , et al. (2021) In European Journal of Cancer 154. p.128-137
- Contribution to journal › Article
Mark Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer
Majid, S. ^LU ; Bendahl, P. O. ^LU ; Huss, L. ^LU ; Manjer, J. ^LU ; Rydén, L. ^LU and Dihge, L. ^LU (2021) In BJS Open 5(3).
- Contribution to journal › Article
Mark Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications
Jørgensen, Charlotte Levin Tykjær ^LU ; Larsson, Anna Maria ^LU ; Forsare, Carina ^LU ; Aaltonen, Kristina ^LU ; Jansson, Sara ^LU ; Bradshaw, Rachel ; Bendahl, Pär Ola ^LU and Rydén, Lisa ^LU (2021) In Cancers 13(7).
- Contribution to journal › Article
Mark Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
Berger, Karoline ; Rhost, Sara ; Rafnsdóttir, Svanheiður ; Hughes, Éamon ; Magnusson, Ylva ; Ekholm, Maria ^LU ; Stål, Olle ; Rydén, Lisa ^LU and Landberg, Göran ^LU (2021) In BMC Cancer 21(1).
- Contribution to journal › Article
Mark Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer : results from the randomized SweBCG91RT trial
Strell, Carina ; Stenmark Tullberg, Axel ; Jetne Edelmann, Reidunn ; Akslen, Lars Andreas ; Malmström, Per ^LU ; Fernö, Mårten ^LU ; Holmberg, Erik ; Östman, Arne and Karlsson, Per (2021) In Breast Cancer Research and Treatment 187(1). p.45-55
- Contribution to journal › Article
Mark St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
Narbe, U. ^LU ; Bendahl, P. O. ^LU ; Fernö, M. ^LU ; Ingvar, C. ^LU ; Dihge, L. ^LU and Rydén, L. ^LU (2021) In The British journal of surgery 108(12). p.1465-1473
- Contribution to journal › Article
Mark Quality assessment of locoregional breast cancer radiotherapy in the international SENOMAC-trial.
Alkner, Sara ^LU ; Lundstedt, Dan ; Wieslander, Elinore ^LU ; M, Berg ; Fagerström Kristensen, Ingrid ^LU ; Ahlgren, J. ; Offersen, B. ; de Boniface, J. and Nissen, H. (2021) European Society Radiation Oncology 2021 In Radiotherapy and Oncology 161(Suppl 1). p.43-43
- Contribution to journal › Published meeting abstract
2020
Mark Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
Sjöström, Martin ^LU ; Laura Chang, S. ; Fishbane, Nick ; Davicioni, Elai ; Hartman, Linda ^LU ; Holmberg, Erik ; Feng, Felix Y. ; Speers, Corey W. ; Pierce, Lori J. and Malmström, Per ^LU , et al. (2020) In Clinical Cancer Research 26(1). p.171-182
- Contribution to journal › Article
Mark PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura ^LU ; Westbom-Fremer, Sofia ^LU ; Arildsen, Nicolai Skovbjerg ^LU ; Hartman, Linda ^LU ; Malander, Susanne ^LU ; Kannisto, Päivi ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2020) In Virchows Archiv: an international journal of pathology 477(1). p.83-91
- Contribution to journal › Article
Mark Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
Tutzauer, Julia ^LU ; Sjöström, Martin ^LU ; Bendahl, Pär Ola ^LU ; Rydén, Lisa ^LU ; Fernö, Mårten ^LU ; Fredrik Leeb-Lundberg, L. M. ^LU and Alkner, Sara ^LU (2020) In PLoS ONE 15(4).
- Contribution to journal › Article

« previous
1
…
5
6
7
8
…
15
next »